Cerus Obtains Exclusive Rights to INTERCEPT Blood System from Baxter - Research and Markets offers a transcript of 'Cerus' Conference Call.DUBLIN, Ireland -- The Cerus (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CERS) Corporate Conference Call took place on 13-Feb-06 11:00am ET. Co. reported that it gained worldwide commercial rights for the INTERCEPT intercept in mathematical terms the points at which a curve cuts the two axes of a graph. Blood System for platelets and plasma from Baxter. Together with the rights granted in Feb. 2005, CERS now holds the exclusive right to the INTERCEPT Blood System for all three commonly transfused components (platelets, plasma, and red blood cells Red blood cells Cells that carry hemoglobin (the molecule that transports oxygen) and help remove wastes from tissues throughout the body. Mentioned in: Bone Marrow Transplantation red blood cells ). More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/80155 This document provides verbatim ver·ba·tim adj. Using exactly the same words; corresponding word for word: a verbatim report of the conversation. adv. text of the conference call. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion